Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Tempest Therapeutics, Inc. (TPST) had Weighted-Average Shares Outstanding (Diluted) of 2.15M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-41.84M |
|
-- |
|
-- |
|
$42.03M |
|
$-42.03M |
|
$0.18M |
|
$-41.84M |
|
$-41.84M |
|
$-41.84M |
|
$-41.84M |
|
$-41.84M |
|
$-41.84M |
|
$-42.03M |
|
$-41.64M |
|
2.15M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.15M |
$-19.51 |
|
$-19.51 |
|
| Balance Sheet Financials | |
$31.47M |
|
$0.89M |
|
$10.01M |
|
$41.49M |
|
$14.22M |
|
-- |
|
$8.14M |
|
$22.36M |
|
$19.13M |
|
$19.13M |
|
$19.13M |
|
3.38M |
|
| Cash Flow Statement Financials | |
$-33.03M |
|
$-0.43M |
|
$24.50M |
|
$39.67M |
|
$30.71M |
|
$-8.96M |
|
$5.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.46M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-218.78% |
|
-218.78% |
|
-100.86% |
|
-218.78% |
|
$5.66 |
|
$-15.60 |
|
$-15.39 |
|